Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leif Mosekilde

Showing results (21-30 of 159) with videos related to

Pageof 16
Sort By:
Contraception|November 19, 2008
The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish womenPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Ugeskrift for Laeger|September 6, 2005
[Hyperthyroidism and risk of atrial fibrillation or flutter--secondary publication. A population-based study]Lars Frost, Peter Vestergaard, Leif Mosekilde
Drugs|January 19, 2013
The pathogenesis, treatment and prevention of osteoporosis in menLeif Mosekilde, Peter Vestergaard, Lars Rejnmark
Calcified Tissue International|January 26, 2008
Selective serotonin reuptake inhibitors and other antidepressants and risk of fracturePeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Scandinavian Journal of Public Health|July 25, 2006
Socioeconomic aspects of fractures within universal public healthcare: a nationwide case-control study from DenmarkPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
BMJ Clinical Evidence|May 6, 2011
Fracture prevention in postmenopausal womenPeter Vestergaard, Leif Mosekilde, Bente Langdahl
Ugeskrift for Laeger|February 1, 2011
[Denosumab--a new efficient osteoporosis therapy]Lars Rejnmark, Peter Vestergaard, Leif Mosekilde
Journal of Hypertension|February 10, 2006
Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control studyLars Rejnmark, Peter Vestergaard, Leif Mosekilde
Maturitas|January 18, 2006
Fracture reducing potential of hormone replacement therapy on a population levelPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 16, 2004
Osteoporosis is markedly underdiagnosed: a nationwide study from DenmarkPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Pageof 16

Showing results (21-30 of 159) with videos related to

Sort By:
Pageof 16
Contraception|November 19, 2008
The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish womenPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Ugeskrift for Laeger|September 6, 2005
[Hyperthyroidism and risk of atrial fibrillation or flutter--secondary publication. A population-based study]Lars Frost, Peter Vestergaard, Leif Mosekilde
Drugs|January 19, 2013
The pathogenesis, treatment and prevention of osteoporosis in menLeif Mosekilde, Peter Vestergaard, Lars Rejnmark
Calcified Tissue International|January 26, 2008
Selective serotonin reuptake inhibitors and other antidepressants and risk of fracturePeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Scandinavian Journal of Public Health|July 25, 2006
Socioeconomic aspects of fractures within universal public healthcare: a nationwide case-control study from DenmarkPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
BMJ Clinical Evidence|May 6, 2011
Fracture prevention in postmenopausal womenPeter Vestergaard, Leif Mosekilde, Bente Langdahl
Ugeskrift for Laeger|February 1, 2011
[Denosumab--a new efficient osteoporosis therapy]Lars Rejnmark, Peter Vestergaard, Leif Mosekilde
Journal of Hypertension|February 10, 2006
Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control studyLars Rejnmark, Peter Vestergaard, Leif Mosekilde
Maturitas|January 18, 2006
Fracture reducing potential of hormone replacement therapy on a population levelPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 16, 2004
Osteoporosis is markedly underdiagnosed: a nationwide study from DenmarkPeter Vestergaard, Lars Rejnmark, Leif Mosekilde
Pageof 16